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ABSTRACT

ARTICLE HISTORY

Protection against liver injury and its consequences is considered an essential issue to minimize the
number of annual deaths caused by liver diseases. The present study was designed to evaluate the
potential role of pomegranate extract (PE) and/or curcumin in the regression of thioacetamide (TAA)induced liver fibrosis, focusing on their modulatory effects on Nrf2/HO-1, NF-jB, and TGF-b/Smad3 signaling pathways. Liver fibrosis was induced in male Wistar rats by intraperitoneal injection of TAA
(100 mg/kg) three times a week, for 8 weeks. To assess the protective effects of PE and/or curcumin
against TAA-induced liver fibrosis, rats were treated on a daily basis with oral doses of PE (200 mg/kg)
and/or curcumin (200 mg/kg) for 8 weeks. The results indicated that PE and/or curcumin attenuated
TAA-induced liver fibrogenesis, as evidenced by a significant improvement in the liver function tests
(AST, ALT, ALP, and albumin), oxidative stress biomarkers (MDA, SOD, and GSH), and inflammatory biomarkers (NF-ŒB, TNF-a, IL-1b, iNOS, TGF-b, and MPO), compared to TAA group. Moreover, treatment
with PE and/or curcumin exerted a significant upregulation of Nrf2/HO-1 gene expressions along with
significant downregulation of NF-ŒB, TGF-b, and phospho-Smad3 protein expressions, as well as a-SMA
and collagen-1 gene expressions. The histopathological examination has corroborated these findings.
In conclusion, hepatoprotective activities of PE and/or curcumin could be linked to their abilities to
modulate Nrf2/HO-1, NF-jB, and TGF-b/Smad3 signaling pathways. It is worth noting that the combination of PE and curcumin exerted superior hepatoprotective effects against TAA-induced liver fibrosis,
as compared to monotherapy.
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Introduction
Liver disease is considered a major culprit of morbidity and
mortality, it involves progressive destruction and regeneration of liver parenchyma, resulting in steatosis, chronic
hepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma
(HCC) (Hong et al. 2015). Hepatic fibrosis is the result of a
wound-healing response caused by a chronic liver injury.
Hepatic stellate cells (HSCs), the main extracellular matrix
(ECM)-producing cells, change to myofibroblast-like cells and
thus produce a large amount of ECM proteins like type I collagen, which leads to liver fibrosis and subsequent cirrhosis
(Hernandez-Gea and Friedman 2011; El-Baz et al. 2019).
Thioacetamide (TAA) is a commonly used hepatotoxin in
animal models, it has been used as a fungicide and organic
solvent (Amin et al. 2012). Chronic administration of TAA can
lead to liver fibrosis, liver cirrhosis, and HCC. The advantages
of TAA as a model hepatotoxin include its high specificity for
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the liver, together with producing histological and biochemical alterations similar to those observed in human liver
injury (Nada et al. 2015). The hepatotoxic effect of TAA is
due to its metabolic activation by microsomal cytochrome
P450 isozyme 2E1 (CYP2E1) to thioacetamide sulfoxide
(TAASO), and further to a reactive metabolite, thioacetamideS, S-dioxide (TAASO2), which binds covalently to liver macromolecules, leading to induction of oxidative stress, thus
accelerating liver fibrosis (Li et al. 2012).
Pro-inflammatory cytokines play key pathogenic roles in
liver injury. Inevitably, the production of these cytokines is
controlled by nuclear factor-kappa B (NF-jB), which is normally located in the cytoplasm bound to inhibitory proteins
(IjB), and activated by various stimuli, such as inflammation
and/or oxidative stress (Shen et al. 2014; Hasan et al. 2016).
Activation of NF-jB pathway induces the gene expression of
an array of distinct pro-inflammatory mediators, such as
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tumor necrosis factor-a (TNF-a), interleukin-1-b (IL-1b), inducible nitric oxide synthase (iNOS), and transforming growth
factor-b (TGF-b), thus participating in the development of
chronic inflammation, which, in turn, promotes hepatic fibrosis (Mantawy et al. 2012; Hassan and Ghobara 2016). TGF-b is
one of the most potent pro-fibrogenic mediators that promotes the activation of HSCs to produce type I collagen and
a-smooth muscle actin (a-SMA). TGF-b/Smad signaling pathway plays a crucial role in the development of liver fibrosis
where TGF-b interacts with its receptors, leading to phosphorylation of the downstream proteins, namely Smad2 and
Smad3 which form complex with Smad4 that translocates
into the nucleus and regulates the expression of target
genes, including type I collagen and a-SMA (Cheng et al.
2017; Chunhua and Hongyan 2017). Undeniably, Smad3 activation via its phosphorylation is directly implicated in the
morphological and functional maturation of fibrogenic cells
(Chen et al. 2014; Fan et al. 2017).
The deleterious effect of the inflammatory response is
associated with augmentation of reactive oxygen species
(ROS) and oxidative damage that inhibit defense mechanisms, such as superoxide dismutase (SOD), glutathione
(GSH), and nuclear factor erythroid 2-related factor 2 (Nrf2).
The latter plays a pivotal role in the protection against oxidative and inflammatory damage through its ability to eliminate ROS, resulting in the inhibition of NF-jB, which further
paves the way for the crosstalk between NFrB and Nrf2
pathways (Bishr et al. 2018; Mittal et al. 2018). Modulation of
Nrf2 signaling has emerged as an essential curator of cellular
oxidative status. Hence, Nrf2 enhancers are promising
innovative candidates for the treatment of oxidative stressrelated diseases. It has been recognized that Nrf2 enhancers
promote the release of Nrf2 from its combination with Kelchlike ECH-associated protein 1 (Keap1) by disrupting the
Keap1-Nrf2 interactions or by enhancing the degradation of
Keap1. Nrf2 is then translocated to the nucleus and binds to
the antioxidant response element (ARE) which, in turn,
increases the transcription of an assortment of antioxidant
genes, such as heme-oxygenase-1 (HO-1), SOD, and GSH. In
addition, the HO-1 antioxidant effect stems from its capacity
to catalyze the breakdown of the pro-oxidant heme into
iron, biliverdin, and carbon monoxide (CO) (Mohamed et al.
2017; Kandeil et al. 2018).
Conventional or synthetic drugs used in the management
of liver diseases have serious adverse effects, especially when
administered chronically (Hasan et al. 2016). Therefore, the
use of natural agents in ameliorating both oxidative stress
and inflammation has been proposed as a mainstream
choice to counteract liver diseases (Nada et al. 2015; Li et al.
2016). Besides, several lines of evidence suggested that natural polyphenolic compounds possess marked free radical
scavenging, antioxidant, and anti-inflammatory properties
(Karimi-Khouzani et al. 2017; Ibrahim et al. 2018). Curcumin is
a polyphenolic compound that is found in turmeric (Curcuma
longa). Curcumin has several beneficial effects, including antioxidant, anti-inflammatory, and anti-carcinogenic activities
(El-Agamy 2010). Pomegranate (Punica granatum L.) has
been extensively used in folk medicine. It constitutes high
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amounts of phenolic compounds, including flavonoids
(anthocyanins, catechins, and other complex flavonoids), and
hydrolyzable tannins (ellagic acid, punicalin, corilagin, pedunculagin, and gallic acid) (Ismail et al. 2012; Middha et al.
2013). Pomegranate extract (PE) shows superior effects to
those of its single constituents possibly due to the synergistic action of its polyphenolic constituents (Ahmed et al.
2014). These bioactive compounds possess diverse biological
activities, such as quenching of ROS, and minimizing the risk
of chronic diseases, such as cancers and cardiovascular disorders (Mphahlele et al. 2016; Wang et al. 2018). Pomegranate
has attracted immense attention for its diverse beneficial
effects, including antioxidant, neuroprotective, and antiinflammatory activities (Husain et al. 2018).
Combination therapy protocols offer great benefits in
daily clinical practice and may be considered as a promising
therapeutic strategy in controlling liver injury (Nada et al.
2015). According to this paradigm, the aim of the present
study was directed to investigate the ameliorative effects of
a combination of pomegranate extract (PE) and curcumin
against TAA-induced liver fibrosis in rats, focusing on its
modulatory effects on Nrf2/HO-1, NF-jB, and TGF-b/Smad3
signaling pathways.

Materials and methods
Chemicals
Thioacetamide (TAA) was purchased from Sigma-Aldrich
Company, St. Louis, MO; curcumin was purchased from
Sigma-Aldrich Company, and pomegranate extract (PE) was
obtained from Holland & Barrett, Nuneaton, UK. The major
chemical constituents of pomegranate peel extract were
identified using liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS/MS), as depicted in
Supplementary File 1. All other chemicals used in the current
study were of the highest analytical grade available.

Preparation of drugs
Thioacetamide was dissolved in sterile distilled water (Patil
and Salunkhe 2016). Curcumin and PE were suspended in
1% tween 80 in distilled water (Zaki and Abdelsalam 2013;
Battineni et al. 2017).

Animals
Adult male Wistar rats weighing 150–170 g were obtained
from the animal house at the National Research Center (Giza,
Egypt), and acclimatized for 1 week before the experiment
started. The animals were supplied with the standard laboratory diet and tap water ad libitum. The rats were housed in
an air-conditioned room at 22–25  C, and humidity about
40–50%, with a 12-h light/dark cycle. All animals received
human care and the study protocols were in compliance
with institutional guidelines for the use of laboratory animals.
The study was approved by the Ethics Committee for Animal
Experimentation at Faculty of Pharmacy, Cairo University

622

A. M. H. GOWIFEL ET AL.

Table 1. Experimental design.
Group number
Group (1)
Group
Group
Group
Group

(2)
(3)
(4)
(5)

Treatment/dose/route
Received 1% tween 80 in distilled water orally (5 ml/kg), daily and intraperitoneally (i.p.) injected with sterile distilled water (5 ml/kg) three
times a week, for 8 weeks (normal control group)
TAA (100 mg/kg, i.p.) three times a week, for
Received 1% tween 80 in distilled water orally, daily, for 8 weeks
8 weeks
Rats were given curcumin (200 mg/kg, p.o.), daily, for 8 weeks
Rats were given PE (200 mg/kg, p.o.), daily, for 8 weeks
Rats were treated daily with PE (200 mg/kg, p.o.), and curcumin (200 mg/kg, p.o.)
for 8 weeks.

(Permit number: PT 1920), and complied with the Guide for
Care and Use of Laboratory Animals published by the US
National Institutes of Health (NIH publication No. 85–23,
revised 2011).

from Biodiagnostic, Inc. (Dokki-Giza, Egypt). Serum alkaline
phosphatase (ALP) activity and albumin level were determined according to methods of Belfield and Goldberg
(1971), and Doumas et al. (1971), respectively using kits purchased from Biodiagnostic, Inc. (Egypt).

Experimental design
Forty healthy male rats were randomly allocated into five
groups (n ¼ 8) and were treated as follows (Table 1).
Group (1): Received 1% tween 80 in distilled water orally
(5 ml/kg), daily and intraperitoneally (i.p.) injected with sterile
distilled water (5 ml/kg) three times a week, for 8 weeks (normal control group). Groups (2–5): Rats were injected with
TAA (100 mg/kg, i.p.) three times a week, for 8 weeks
lu et al. 2015), and the following treatments were
(Bahçecıog
given concomitantly with TAA for 8 weeks: Group (2): Rats
received 1% tween 80 in distilled water orally, daily; Group
(3): Rats were given curcumin (200 mg/kg, p.o.), daily (ElAgamy 2010), Group (4): Rats were given PE (200 mg/kg,
p.o.), daily (Abozid and Farid 2013), and Group (5): Rats were
treated daily with PE (200 mg/kg, p.o.), and curcumin
(200 mg/kg, p.o.).
At the end of the experiment, blood samples were withdrawn from the retro-orbital vein of each animal under anesthesia (xylazine 10 mg/kg and ketamine 75 mg/kg; i.p),
according to the method described by Cocchetto and
Bjornsson (1983). Blood samples were allowed to coagulate,
then centrifuged at 1000  g for 15 min to obtain clear sera
for estimation of the liver function tests. Immediately after
collection of blood samples, anesthetized rats were sacrificed
by decapitation, then livers were rapidly removed, washed in
normal saline, and blotted with filter paper. Afterward, each
liver was divided into four parts, the first part (1 g) was
homogenized with ice-cold saline (0.9% NaCl) to prepare
20% w/v homogenate which was centrifuged at 2000  g
for 5 min. at 4  C. The prepared homogenates were divided
into several aliquots that were used for the determination of
the biochemical parameters. The second and third parts
were kept at 80  C and were later used for real-time PCR
analysis, and western blot analysis. The fourth part was
placed in 10% (v/v) buffered formalin/saline for histopathological and histochemical examinations.

Determination of the serum liver function tests
Serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities were determined according to the
methods of Reitman and Frankel (1957), using kits purchased

Determination of liver oxidative stress biomarkers
Estimation of liver lipid peroxidation (LPO) as liver malondialdehyde (MDA) content was carried out according to the
method described by Ohkawa et al. (1979), using a kit purchased from Biodiagnostic, Inc. Determination of liver superoxide dismutase (SOD) activity and reduced glutathione
(GSH) content were carried out according to methods of
Nishikimi et al. (1972), and Beutler et al. (1963), respectively
using kits purchased from Biodiagnostic, Inc. (Egypt).

Determination of liver inflammatory biomarkers using
enzyme-linked immunosorbent assay (ELISA)
The tissue contents of TNF-a, IL-1b, iNOS, TGF-b, and myeloperoxidase (MPO) were determined according to instructions
of the manufacturer, using ELISA kits of Raybiotech, Norcross,
GA (Catalog# ELR-TNFalpha-001C); CUSABIO, China (Catalog#
CSB-E08055r); MyBiosource, San Diego, CA (Catalog#
MBS263618), Kamiya Biomedical Company, Seattle, WA
(Catalog# KT-30309), and Hycult Biotech, Uden, The
Netherlands (Catalog# HK 105), respectively.
Nuclear factor-kappa B-p65 (NF-jB-p65) was measured in
nuclear extract using an ELISA kit from MyBiosource, San
Diego, CA (Catalog# MBS704916). Nuclear extract was prepared from liver tissues using a nuclear extraction reagent
kit following the manufacturer’s protocol (MyBiosource).

Western blot analysis of NF-jB-p65, TGF-b, and
phosphorylated-Smad3 (phospho-Smad3)
protein expression
Briefly, total proteins were extracted from hepatic tissue samples using radioimmunoprecipitation assay (RIPA) buffer, containing 1.5 ml 5 M NaCl, 1 mM phenylmethylsulfonyl fluoride,
2.5 ml 10% deoxycholic acid, 0.5 ml 10% sodium dodecyl sulfate (SDS), and 2.5 ml 1 M Tris (pH 8.6). The tissue lysate was
centrifuged at 16 000  g for 20 min at 4  C. The lysate was
then collected and protein concentration was determined
using a bicinchoninic acid (BCA) protein assay kit (Thermo
Fisher Scientific Inc., Waltham, MA). Following protein quantification, 20 mg of protein from each sample was loaded with
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an equal volume of Laemmli sample buffer, then samples
were separated onto 8% SDS-polyacrylamide gel electrophoresis, and transferred to a nitrocellulose membrane
(Amersham Bioscience, Piscataway, NJ) using a semidry transfer apparatus (Bio-Rad, Hercules, CA). The membrane was
blocked with 6% nonfat dried milk in tris-buffered saline
(TBS) containing 0.1% Tween 20 at 4  C for 3 h. The membrane was then washed with TBS-Tween buffer and incubated overnight on a roller shaker at 4  C with one of the
following primary antibodies: nuclear factor-kappa B-p65 (NFjB-p65), transforming growth factor-b (TGF-b), total Smad3
(Smad3), phospho-Smad3 (P-Smad3) (Ser 423, Ser 425) or
b-actin (b-actin) (Thermo Fisher Scientific). The membrane
was washed and subsequently probed with horseradish peroxidase-conjugated goat anti-mouse immunoglobulin
(Amersham.
Life
Science
Inc.,
Waltham,
MA).
Chemiluminescence detection was done using an Amersham
detection kit according to the manufacturer’s protocols and
exposed to X-ray film. The amount of protein was quantified
by densitometric analysis of the autoradiograms using a
scanning laser densitometer (Biomed Instrument Inc., Clinton
Township, MI).

Quantitative real-time polymerase chain reaction (qRTPCR) analysis of Nrf2, HO-1, a-SMA, and collagen-1
gene expression
Isolation of total RNA from rat liver samples was done using
RNeasy Mini Kit (Qiagen GmbH, Hilden, Germany). Reverse
transcription and qRT-PCR were performed using QuantiTect
SYBRV Green PCR Kit (Qiagen GmbH, Hilden, Germany),
according to the manufacturer’s protocol. The cycling conditions were as follows: reverse transcription at 50  C for
30 min, initial denaturation at 95  C for 10 min, followed by
40 cycles of denaturation at 95  C for 15 s, annealing at 60  C
for 1 min and extension at 72  C for 30 s. The relative expression of the target genes (b-actin, Nrf2, HO-1, a-SMA, and collagen-1) was calculated by the following formula: 2DDCt as
described previously by Livak and Schmittgen (2001) using
b-actin as control housekeeping gene for normalization. The
sequences of primers are depicted in Table 2.
R

Histopathological examinations
The specimens from livers were taken and fixed immediately
in 10% (v/v) buffered formalin/saline followed by dehydration in gradual dilutions of alcohol, clearing in xylene, and
embedding in paraffin wax. Liver sections (4–5 mm thickness)
were stained with Hematoxylin and Eosin (H & E) to verify
histological details and Masson’s trichrome (MTC) to

demonstrate the collagen fibers according to the previously
described method by Bancroft and Gamble (2002).

Statistical analysis
Data were analyzed by using Graph Pad Prism v. 6.0 (Graph
Pad Software, Inc., LaJolla, CA). Results are expressed as
mean ± standard error of the mean (SEM). Data were analyzed by one-way analysis of variance (ANOVA) test followed
by the Tukey–Kramer multiple comparison test. Statistical significance was considered at p < 0.05.

Results
Effect of PE and/or curcumin on serum liver function
tests in TAA-intoxicated rats
As depicted in Table 3, rats subjected to TAA revealed
marked impairment in liver functions. TAA produced a significant elevation in serum AST, ALT, and ALP activities by
7.5-folds, 7-folds, and 3-folds, respectively, accompanied by
significant suppression in serum albumin level by 59%, as
compared to the normal control group. On the contrary, the
administration of curcumin exerted a significant decrement
in serum AST, ALT, and ALP activities by 53, 31, and 32%,
respectively, along with a significant increment in serum
albumin level by 48%, as compared to TAA control group.
The administration of PE produced a significant reduction in
serum AST, ALT, and ALP activities by 73, 61, and 51%,
respectively, together with a significant elevation in serum
albumin level by 98%, as compared to TAA control group.
Moreover, it was noticed that the administration of PE combined with curcumin had normalized serum ALT activity,
while produced a significant decrement in serum AST and
ALP activities by 81 and 59%, respectively, along with a significant increase in serum albumin level by 2-folds, as compared to TAA control group.
Table 3. Effect of PE and/or curcumin on serum liver function tests in TAAintoxicated rats.
Parameters
AST
Groups
(U/ml)
Normal control
34.5 ± 0.82a
TAA control
257.15 ± 2.98b
Curcumin þ TAA
120.88 ± 1.32c
PE þ TAA
70.38 ± 2.27d
PE þ Curcumin þ TAA 48.5 ± 1.31e

ALT
(U/ml)
27.55 ± 1.21a
193.5 ± 1.61b
134.43 ± 2.07c
75.4 ± 1.02d
32.88 ± 1.44a

ALP
(IU/L)
76.22 ± 1.95a
230.82 ± 3.26b
156.62 ± 2.92c
114.21 ± 1.44d
93.77 ± 2.98e

Albumin
(g/dl)
3.99 ± 0.06a
1.65 ± 0.04b
2.44 ± 0.05c
3.27 ± 0.05d
3.66 ± 0.04e

AST: aspartate aminotransferase; ALT: alanine aminotransferase; ALP: alkaline
phosphatase; TAA: thioacetamide; PE: pomegranate extract.
Data are expressed as mean of 8 rats ± SEM (n ¼ 8 rats/group). One-way
ANOVA followed by Tukey-Kramer multiple comparisons test were used for
statistical analysis of data. Within each column, means with different superscript letters are significantly different (p < 0.05).

Table 2. The sequence of primers used for real-time PCR analysis.
Genes
Nrf2
HO-1
a-SMA
Collagen-1
b-actin

Forward primers
50 -GCTATTTTCCATTCCCGAGTTAC-30
50 -CTTTCAGAAGGGTCAGGTGTC-30
50 -GCTCCATCCTGGCTTCTCTATC-30
50 -GAGCGGAGAGTACTGGATCGA-30
50 -CCGTGAAAAGATGACCCAGATC-30
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Reverse primers
50 -ATTGCTGTCCATCTCTGTCAG-30
50 -TGCTTGTTTCGCTCTATCTCC-30
50 -GGGCCAGCTTCGTCATACTC-30
50 -CTGACCTGTCTCCATGTTGCA-30
50 -CACAGCCTGGATGGCTACGT-30

Gene bank accession numbers
NM_031789.2
NM_012580.2
NM_031004.2
NM_053304.1
NM_031144.3
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Figure 1. The effect of oral administration of PE and/or curcumin on liver MDA content (a), SOD activity (b), and GSH content (c) in TAA-intoxicated rats. Data are
expressed as mean of 8 rats ± SEM (n ¼ 8 rats/group). One-way ANOVA followed by Tukey–Kramer multiple comparisons test were used for statistical analysis of
data (groups with different letters are significantly different at p < 0.05). MDA: malondialdehyde; SOD: superoxide dismutase; GSH: reduced glutathione; TAA: thioacetamide; PE: pomegranate extract.

Effect of PE and/or curcumin on liver oxidative stress
biomarkers in TAA-intoxicated rats
As illustrated in Figure 1(a–c), TAA insult triggered an imbalance in cellular oxidative status. A significant upsurge in liver
MDA content by 4.5-folds paralleled with a significant reduction in both liver SOD activity and liver GSH content by
nearly 61% was observed in TAA-intoxicated rats in comparison to the normal control group. Contrariwise, the administration of curcumin significantly hampered liver MDA
content by 43%, while significantly elevated both liver SOD
activity and liver GSH content by 74 and 56%, respectively,
as compared to TAA control group. Treatment with PE
caused a significant decline in liver MDA by 61%, along with
a significant increment in both liver SOD activity and liver
GSH content by 104 and 98%, respectively, as compared to
the TAA control group. Notably, administration of PE combined with curcumin normalized liver MDA content, while

significantly elevated both liver SOD activity and liver GSH
content by approximately 2.3-folds, as compared to the TAA
control group.

Effect of PE and/or curcumin on liver mRNA expression
of Nrf2 and HO-1 in TAA-intoxicated rats
As illustrated in Figure 2(a,b), TAA-induced hepatotoxicity
caused a significant drop in liver mRNA expression of both
Nrf2 and HO-1 by 73% and 65%, respectively, as compared
to the normal control group. On the other hand, the administration of curcumin significantly elevated liver mRNA
expression of both Nrf2 and HO-1 by 89 and 47%, respectively, compared to the TAA-intoxicated group. Likewise,
treatment with PE significantly elevated liver mRNA expression of both Nrf2 and HO-1 by 2.5-folds and 2-folds, respectively, compared to the TAA-intoxicated group. It is worth
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Figure 2. The effect of oral administration of PE and/or curcumin on liver mRNA expression of Nrf2 (a) and HO-1 (b) in TAA-intoxicated rats. Data are expressed as
mean of 8 rats ± SEM (n ¼ 8 rats/group). One-way ANOVA followed by Tukey–Kramer multiple comparisons test were used for statistical analysis of data (groups
with different letters are significantly different at p < 0.05). Nrf2: nuclear factor erythroid 2-related factor 2; HO-1: heme-oxygenase-1; TAA: thioacetamide; PE: pomegranate extract.

mentioning that treatment with a combination of PE and
curcumin normalized liver mRNA expression of Nrf2, while
significantly increased liver mRNA expression of HO-1 by 2.5folds, as compared to the TAA control group.

and 68%, respectively, as compared to the TAA control
group. Noteworthy, treatment with PE combined with curcumin reverted liver protein expression of both NF-jB-p65 and
TGF-b back to their normal values.

Effect of PE and/or curcumin on liver inflammatory
biomarkers in TAA-intoxicated rats

Effect of PE and/or curcumin on liver protein expression
of phosphorylated-Smad3 (Phospho-Smad3/total
Smad3) in TAA-intoxicated rats

As illustrated in Figure 3(a–f), induction of liver injury by TAA
was associated with significant elevation in liver NF-ŒB-p65,
TNF-a, IL-1b, iNOS, TGF-b, and MPO contents by 8.7-folds,
4.3-folds, 4.15-folds, 9-folds, 6-folds, and 4-folds, respectively,
as compared to the normal control group. On the other
hand, administration of curcumin exerted a significant diminution in liver NF-ŒB-p65, TNF-a, IL-1b, iNOS, TGF-b, and MPO
contents by 65, 53, 46, 56, 65, and 49%, respectively, as compared to TAA control group. Treatment with PE significantly
reduced liver NF-ŒB-p65, TNF-a, IL-1b, iNOS, TGF-b, and MPO
contents by 73.5, 64, 60, 68, 72, and 63%, respectively, as
compared to TAA control group. Notably, administration of
PE combined with curcumin caused normalization of liver
NF-ŒB-p65, TNF-a, and TGF-b contents, while significantly
decreased liver IL-1b, iNOS, and MPO contents by 70, 78, and
69.9%, respectively, as compared to TAA control group.

Effect of PE and/or curcumin on liver protein expression
of NF-jB-p65, and TGF-b in TAA-intoxicated rats
As illustrated in Figure 4(a,b), TAA intoxication exerted a significant increase in liver protein expression of both NF-jBp65 and TGF-b by 9.4-folds and 10.5-folds, respectively, as
compared to the normal control group. Contrariwise, the
administration of curcumin produced a significant decrement
in liver protein expression of both NF-jB-p65 and TGF-b by
38 and 49%, respectively, as compared to the TAA control
group. Moreover, treatment with PE significantly reduced
liver protein expression of both NF-jB-p65 andTGF-b by 58%

As illustrated in Figure 5, the rats subjected to TAA intoxication exhibited a significant upsurge in liver protein expression of phospho-Smad3 by 9.8-folds, as compared to the
normal control group. Moreover, the administration of curcumin produced a significant reduction in liver protein expression of phospho-Smad3 by 41%, as compared to the TAA
control group. In addition, treatment with PE significantly
reduced liver protein expression of phospho-Smad3 by 61%,
as compared to the TAA control group. Noteworthy, treatment with PE combined with curcumin reverted liver phospho-Smad3 protein expression back to its normal values.

Effect of PE and/or curcumin on liver mRNA expression
of a-SMA and collagen-1 in TAA-intoxicated rats
As illustrated in Figure 6(a,b), TAA-intoxicated rats demonstrated significant spikes in liver mRNA expression of both
a-SMA and collagen-1 by about 12-folds, as compared to the
normal control group. Treatment with curcumin produced a
significant decrement in liver mRNA expression of both
a-SMA and collagen-1 by 48 and 52%, respectively, as compared to the TAA control group. The administration of PE
significantly reduced liver mRNA expression of both a-SMA
and collagen-1 by 62 and 67%, respectively, as compared to
the TAA control group. Interestingly, the administration of PE
combined with curcumin normalized liver mRNA expression
of collagen-1, while significantly decreased liver mRNA
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Figure 3. The effect of oral administration of PE and/or curcumin on liver NF-jB-p65 (a), TNF-a (b), IL-1b (c), iNOS (d), TGF-b (e), and MPO contents (f) in TAAintoxicated rats. Data are expressed as mean of 8 rats ± SEM (n ¼ 8 rats/group). One-way ANOVA followed by Tukey–Kramer multiple comparisons test were used
for statistical analysis of data (groups with different letters are significantly different at p < 0.05). NF-jB: nuclear factor kappa; TNF-a: tumor necrosis factor-a; IL-1b:
interleukin-1-b; iNOS: inducible nitric oxide synthase; MPO: myeloperoxidase; TGF-b: transforming growth factor-b; TAA: thioacetamide; PE: pomegranate extract.
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Figure 4. The effect of oral administration of PE and/or curcumin on liver NF-jB-p65 (a), and TGF-b (b) protein expression in TAA-intoxicated rats. Data are
expressed as mean of 8 rats ± SEM (n ¼ 8 rats/group). One-way ANOVA followed by Tukey–Kramer multiple comparisons test were used for statistical analysis of
data (groups with different letters are significantly different at p < 0.05). NF-jB: nuclear factor kappa; TGF-b: transforming growth factor-b; TAA: thioacetamide; PE:
pomegranate extract.

collagen fibers deposition that encircled the hepatic lobule
forming pseudolobule, as well as oval cell proliferation, and
severe hepatocellular necrosis (Figure 7(b)). Contrariwise,
treatment with curcumin exhibited scanty collagen deposition in the portal tract, moderate hepatocellular necrosis,
and mild hepatocellular vacuolation (Figure 7(c)). Treatment
with PE showed mild hepatocellular necrosis, together with
mild activation of Kupffer cells (Figure 7(d)). Further, in the
group treated with a combination of PE and curcumin, the
liver sections showed apparent normal hepatic parenchyma
(Figure 7(e)).

Histochemical studies

expression of a-SMA by 78%, as compared to the TAA control group.

The histochemical examination of the normal control rats’
liver sections revealed normal histochemical reaction (Figure
8(a)). The examination of liver sections from TAA control rats
exhibited a strong positive histochemical reaction, indicating
extensive fibrosis with deposition of collagen fibers in the
portal triad and around the hepatic lobules (Figure 8(b)). On
the other hand, treatment with curcumin showed a moderate histochemical reaction for collagen fibers (moderate
fibrotic changes) (Figure 8(c)). Treatment with PE showed
mild histochemical reaction (Figure 8(d)). Interestingly, the
administration of a combination of PE and curcumin showed
improvement in the liver tissue as evidenced by normal
histochemical reaction (Figure 8(e)).

Histopathological studies

Discussion

The histological examination of liver sections from the normal control group showed normal architecture of hepatic
lobules with hepatocytes radiating from the central veins
(Figure 7(a)). The examination of liver sections from TAA control rats depicted disruption of the normal architecture of
hepatic lobules, associated with bridging of fibroblasts and

To the best of our knowledge, this is the first study to report
the beneficial potential of the combination of pomegranate
extract (PE) and curcumin against the liver fibrosis induced
by thioacetamide (TAA) in rats, focusing on its modulatory
effects on Nrf2/HO-1, NF-jB, and TGF-b/Smad3 signaling
pathways. Combination therapies are becoming increasingly

Figure 5. The effect of oral administration of PE and/or curcumin on liver phospho-Smad3 protein expression (P-Smad3/Smad3) in TAA-intoxicated rats. Data
are expressed as mean of 8 rats ± SEM (n ¼ 8 rats/group). One-way ANOVA followed by Tukey–Kramer multiple comparisons test were used for statistical analysis of data (groups with different letters are significantly different at p < 0.05).
Phospho-Smad3: phosphorylated-Smad3; Smad3: total Smad3; TAA: thioacetamide; PE: pomegranate extract.
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Figure 6. The effect of oral administration of PE and/or curcumin on liver mRNA expression of a-SMA (a) and collagen-1 (b) in TAA-intoxicated rats. Data are
expressed as mean of 8 rats ± SEM (n ¼ 8 rats/group). One-way ANOVA followed by Tukey–Kramer multiple comparisons test were used for statistical analysis of
data (groups with different letters are significantly different at p < 0.05). a-SMA: a-smooth muscle actin; TAA: thioacetamide; PE: pomegranate extract.

Figure 7. Photomicrographs of liver sections stained with H&E at 400. (a) Normal control group showing normal histological structure of hepatic lobule from central vein (CV) and hepatocytes (H). (b) Rats injected with TAA showing disruption of normal architecture of hepatic lobules, associated with bridging of fibroblasts
and collagen fibers deposition that encircled the hepatic lobule forming pseudolobule (small arrow), as well as oval cell proliferation (large arrow), and severe hepatocellular necrosis (arrow head). (c) Rats treated with curcumin showing scanty collagen deposition in portal tract (small arrow), moderate hepatocellular necrosis
and mild hepatocellular vacuolation (large arrow). (d) Rats treated with PE showing mild hepatocellular necrosis, together with mild activation of Kupffer cells
(arrow). (e) Rats treated with combination of PE and curcumin showing apparent normal hepatic parenchyma.

popular, as they improve clinical outcomes by targeting a
multitude of pathways with the potential likelihood of having synergistic effects (Ravindranathan et al. 2018). In fact,
previous studies revealed the hepatoprotective effects of

either PE (Ibrahim et al. 2016; Khan et al. 2017) or curcumin
(El-Agamy 2010; Kabirifar et al. 2018), however, the exact
mechanisms beyond such effects are still not fully clarified.
Besides, attention has been focused toward studying
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Figure 8. Photomicrographs of liver sections stained with Masson’s trichrome (MTC) at 400. (a) Normal control group showing normal histochemical reaction. (b)
Rats injected with TAA showing extensive fibrosis with strong histochemical reaction for collagen fibers in the portal triad and around the hepatic lobules. (c) Rats
treated with curcumin showing moderate histochemical reaction for collagen fibers (moderate fibrotic changes). (d) Rats treated with PE showing mild histochemical reaction. (e) Rats treated with combination of PE and curcumin showing normal histochemical reaction.

signaling pathways underlying the progression of liver diseases to develop new therapies, where controlling Nrf2/HO1, NF-jB, and TGF-b/Smad3 signaling pathways have become
a pharmacological target for management of chronic inflammatory disorders (Chunhua and Hongyan 2017; Fayez et al.
2018). This study not only showed an improvement in the
hepatoprotective properties of either curcumin or PE when
combined with each other but also outlined the molecular
pathways through which curcumin and PE function
cooperatively.
Combined treatment with PE and curcumin afforded a significant reduction in some hallmarks of hepatoxicity including serum AST and ALP as compared to monotherapy and
succeeded to normalize ALT. This indicates the maintenance
of liver cell membrane integrity by both PE and curcumin
hence preventing leakage of liver enzymes into bloodstream
(Salem et al. 2014; Ahmed et al. 2015) that might be attributed to the inhibition of TAA-induced lipid peroxidation
reported herein. In addition, this combination improved the
functions of hepatocytes through the antioxidant properties
of both PE (Tohame et al. 2010) and curcumin (Ezz et al.
2011), which consequently enhanced protein synthesis, as
verified by significant elevation of serum albumin, compared
to monotherapy. The extensive liver injury in TAA-intoxicated
rats may be attributed to the generation of TAA reactive
metabolites which react with the cellular membranes of

hepatocytes, causing hepatocellular damage or cellular
necrosis that leads to both leakages of enzymes into the
bloodstream (Ansil et al. 2011; Nada et al. 2015) and reduction in protein synthesis (Amin et al. 2012). Consistent with
this, the current study showed that TAA intoxication exerted
a profound increase in the serum liver function enzymes
(ALT, AST, and ALP), along with a significant reduction in
serum albumin levels compared to the normal group.
Treatment with a combination of PE and curcumin
resulted in a prominent reduction of liver MDA content,
together with enhancing Nrf2/HO-1 gene expressions, boosting SOD activity, and replenishing GSH stores relative to
monotherapy suggesting that both agents potentiated the
antioxidant and anti-lipid peroxidative effects of each other.
The depicted upregulation of Nrf2 gene expression provides
a plausible justification of the aforementioned amendments.
There is ample evidence that Nrf2 regulates the expression
of several antioxidant genes including HO-1, SOD, and GSH,
where Nrf2 increases the expression of c-glutamylcysteine
ligase (GCL) which catalyzes the rate-limiting step in GSH
biosynthesis (Xiong et al. 2015; Kandeil et al. 2018).
Antioxidant and anti-lipid peroxidative effects of curcumin
were ascribed to its conjugated structure, which includes
two methoxylated phenolic OH groups attached to 1,3-diketone conjugated diene system that is capable of scavenging
free radicals by the resonance stabilization of free radical
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intermediates (Naik et al. 2011; Reddy et al. 2012). Besides,
the polyphenolic constituents of PE scavenge free radicals by
acting as electron donors, which react with free radicals to
convert them to more stable products, thereby terminating
free radical chain reaction and suppressing lipid peroxidation
(Tohame et al. 2010; Ibrahim et al. 2016).
TAA intoxication was accompanied by robust oxidative
stress as manifested by a pronounced spike in liver MDA
content, along with a prominent decline in Nrf2/HO-1 gene
expressions, liver SOD activity, and GSH content, as compared to the normal control group. This can be explained in
the light of the metabolic conversion of TAA into reactive
metabolites, which attack microsomal lipids, leading to their
peroxidation, and generation of ROS (Amin et al. 2012). The
overproduction of ROS was associated with the downregulation of Nrf2 gene expression that led to a subsequent decline
in HO-1, SOD, and GSH production, hence overwhelming
antioxidant defense mechanisms (Ansil et al. 2011; Fayez
et al. 2018; Kandeil et al. 2020). Additionally, ROS was

capable of inducing inflammation through the activation of
IjB kinase (IKK), involved in the NF-jB pathway, thus enhancing both IjB phosphorylation and degradation. This resulted
in NF-ŒB activation via the nuclear translocation of p65 subunit (Lee et al. 2014; Hassan and Ghobara 2016) that consequently led to enhanced production of downstream proinflammatory mediators, such as TNF-a, IL-1b, iNOS, and TGFb, along with their master inflammatory regulator NF-ŒB-p65,
as reported herein. In a sort of positive feedback, these proinflammatory mediators may enhance NF-jB pathway
through the activation of IKK with consequent IjB phosphorylation and degradation, thus allowing the translocation of
NF-jB-p65 to the nucleus and transcription of its downstream pro-inflammatory genes, thereby amplifying the deleterious effects (Ahmed et al. 2014). The elevation of TNF-a
probably enhanced neutrophil infiltration, resulting in elevation of MPO content (Demirel et al. 2011), as reported in the
current study. MPO is released by activated neutrophils and
involved in ROS generation, where MPO catalyzes the

Figure 9. Schematic representation of the proposed mechanisms involved in the hepatoprotective effects of PE and/or curcumin against TAA-induced liver fibrosis
in rats. TAA intoxication resulted in overproduction of ROS, which was associated with the downregulation of Nrf2 gene expression that leads to a subsequent
decline in HO-1, SOD, and GSH production, thus overwhelming antioxidant defense mechanisms. Additionally, ROS were capable of inducing inflammation through
the activation NF-jB pathway, that consequently leads to enhanced production of downstream pro-inflammatory mediators, such as TNF-a, IL-1b, iNOS, and TGFb. Afterwards, TGF-b induces phosphorylation and nuclear translocation of Smad3, thus stimulating the expression of specific TGF-b target genes, including a-SMA
and collagen-1. Contrariwise, both PE and curcumin enhanced Nrf2 gene expression, leading to elevation in the expression of antioxidant genes, including HO-1,
SOD, and GSH, together with their antioxidant and free radical scavenging activities, thus ameliorating oxidative stress. Both curcumin and PE, by virtue of their
antioxidant activities, were capable of inhibiting NF-ŒB activation and, consequently, the generation of its downstream pro-inflammatory mediators. The inhibition
of NF-ŒB activation resulted also in hampering TGF-b, thereby inhibiting phosphorylation of Smad3, which finally led to abrogation of the expression of pro-fibrogenic genes, including a-SMA and collagen-1. Taken together, PE and/or curcumin ameliorated TAA-induced liver fibrosis, where they inhibited oxidative stress,
inflammation and fibrogenesis, via promoting Nrf2/HO-1, along with disrupting of NF-jB/TGF-b/Smad3 pathways. Interestingly, combination of PE and curcumin
exerted more pronounced antioxidant, anti-inflammatory, and anti-fibrotic effects as compared to monotherapy, possibly via synergistic effect between PE and cur) indicate inhibitory actions.
cumin in ameliorating liver fibrosis. Arrows ( ) indicate stimulatory actions and T-shaped arrows (
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reaction between chloride and hydrogen peroxide to produce hypochlorous acid (HOCl) thus exacerbating the oxidative stress (Bekheet et al. 2009).
It was noted that the combination of PE and curcumin
produced better anti-inflammatory effects than those produced by monotherapy, as evidenced by the normalization
of liver NF-ŒB-p65, TNF-a, and TGF-b contents, together with
the protein expression of both NF-ŒB-p65, and TGF-b.
Curcumin and polyphenolic constituents of PE, particularly
ellagic acid and gallic acid, by virtue of their antioxidant
activities, were capable of suppressing IKK activity (van den
Berg et al. 2001; Calabrese et al. 2008; Ahmed et al. 2014),
hence blocking phosphorylation/degradation of IjB and
impeding the nuclear translocation of NF-ŒB-p65, resulting in
the inhibition of NF-ŒB activation and, consequently, the
generation of its downstream pro-inflammatory mediators
(Figueiredo et al. 2016; Guan et al. 2017). Besides, PE and
curcumin were reported to suppress TNF-a-induced neutrophils infiltration, leading to a reduction in liver MPO content
(Mouzaoui et al. 2012; Makled et al. 2016); results that are
quite related to those of the present study.
The existence of a relationship between NF-jB and TGFb/Smad3 signaling pathways was previously reported (Wang
et al. 2015; El-Agroudy et al. 2016). The activation of TGFb/Smad3 signaling pathway was highlighted as a major culprit in TAA-induced liver fibrosis (El-Tanbouly et al. 2017).
The current study showed that rats subjected to TAA intoxication exhibited a significant upsurge in liver protein expression of phospho-Smad3, as well as gene expression of a-SMA
and collagen-1 as compared to the normal control group.
These results could be related to the ability of TAA to promote fibrogenesis via activation of NF-jB, thereby enhancing
TGF-b signaling, through upregulating the expression of TGFb (Hessin et al. 2015; El-Agroudy et al. 2016). Afterward, TGFb binds to its receptors on the cell surface, leading to phosphorylation and nuclear translocation of Smad3, thus stimulating the expression of specific TGF-b target genes,
including a-SMA and collagen-1 (Wang et al. 2015; Tseng
et al. 2016; El-Baz et al. 2019). These results were verified by
histopathological findings that revealed the presence of
fibrosis with abundant connective tissue strands.
The combination of PE and curcumin exerted better
effectiveness in disrupting TGF-b/Smad3 signaling pathway
compared to monotherapy, where this combination reverted
liver phospho-Smad3 protein expression and the gene
expression of collagen-1 back to their normal values. These
results were corroborated by improvement in the histopathological findings that revealed apparent normal liver architecture. These effects may be attributed to the suppression of
NF-jB activation by the combined treatment regimen that
probably resulted in hampering TGF-b, which, in turn, inhibited phosphorylation of Smad3, and finally led to abrogation
of the expression of pro-fibrogenic genes, including a-SMA
and collagen-1. It is noteworthy that this is the first study to
validate the association between TGF-b/Smad3 signaling and
the hepatoprotective effects of PE.
Notably, the polyphenolic constituents present in PE exert
better antioxidant, anti-inflammatory, and anti-fibrotic effects
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when they are used in combination with each other, rather
than individually (Mandal et al. 2017). In conclusion, this
study unveiled some of the potential molecular pathways
involved in the amendment of TAA-induced liver fibrosis by
PE and/or curcumin. Treatment with PE and/or curcumin
inhibited oxidative stress, inflammation, and fibrogenesis, via
promoting Nrf2/HO-1, along with disrupting of NF-jB/TGFb/Smad3 pathways, as recapitulated in Figure 9. The current
results showed that the combination of PE and curcumin
exerted better antioxidant, anti-inflammatory, and antifibrotic effects as compared to monotherapy, thus portraying
a possible synergistic effect between PE and curcumin in
ameliorating liver fibrogenesis. Hopefully, the current study
sheds light on the usage of this combination in the protection against liver diseases, thereby providing preclinical evidence that this combined therapy may be regarded as a
promising avenue for therapeutic intervention in various
liver diseases.
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